Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > CG Oncology NMIBC data

<< Previous

Bullboard Posts

Next >>

Post by Donein25on Dec 01, 2022 2:29pm

396 Views

Post# 35143928

CG Oncology NMIBC data

ScieneFirst. What are we to make of their CG0070? They have released inpressive CRs in small (32 pt.) partnered combo with Keytruda for NMIBC. They are a small private biotech but already have partnered up on combos with BMS Opdivo and Roche Tecentriq. I'd like to see us making deals like this sooner rather than later. Do you see us as more attractive to future partners, when we get to that point in time?.

<< Previous

Bullboard Posts

Next >>

The top TSX healthcare stocks under $1